NeuroSense Therapeutics (NRSN) Q4 2025 Earnings

26NovConfirmed
Q2 2025
Q2 2025
Q3 2025
Q4 2025
-0.22
-0.16
-0.1
-0.04

Details

Expected EPS
-0.0437
Actual EPS
-0.04
Surprise EPS
0
Surprise Percent
+8.47%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.04 per share for Q4 2025.

0 Comments

Share your thoughts